Skip to the content
Search
Beyond Type 1
Menu
BEYOND TYPE 1
Show sub menu
About
Board of Directors
The Team
Leadership Council
Portfolio
Press
Careers
Contact
Join Us
Diabetes
Type 1 Info
Type 2 Info
Diabetes Management
Newly Diagnosed
Forms Of Diabetes
Autoimmune Diseases
Pregnancy with Type 1 Diabetes
Research
Resources
Stories
Diabetes News
Diabetes Management
Diabetes + Exercise
Mental Health + Diabetes
Food and Diabetes
School Resources
Sex, Drugs + Rock & Roll
Travel + Adventure
Previously Healthy
GetInsulin.org
Newsletter
Programs
Beyond Type 1 App
Beyond Barriers
Beyond Scholars
Community Table
GetInsulin.org
Marathon Team
Snail Mail Club
TuDiabetes
Type 1 Signs
Jesse Was Here
Advocacy
Donate
Search
Tag:
Access
The Power in Numbers: Change.org’s Affordable Insulin For All Movement
As insulin prices continue to increase in the United States, Change.org is equipping those affected with the tools to speak out.
New Medicare Plan Will Cap Insulin Copays at $35
On March 11, the Centers for Medicare & Medicaid Services (CMS) launched a new plan for some Medicare Part D participants to pay a maximum $35 copay for their monthly supply of insulin.
JDRF CEO to Health Insurers: Cover New Technology
JDRF President & CEO Aaron Kowalski, Ph.D calls on insurers to cover FDA approved type 1 diabetes technology
Half-Price Generics of NovoLog and NovoLog Mix Announced by Novo Nordisk
Novo Nordisk announced that authorized generic versions of NovoLog and NovoLog Mix will be made available on January 2, 2020.
Senate Bill Aims to Cut Price of Insulin by 75%
The "Insulin Price Reduction Act" would create a new pricing model for insulin, incentivizing manufacturers to lower list prices to 2006 prices.
New Guidance from the US Treasury Opens Door to High Deductible Exemptions for Diabetes Care
The U.S. Treasury issued new guidance which aims to make accessing medications for chronic conditions easier under some insurance plans.
Find The Devices You Need: DiabetesWise
DiabetesWise is dedicated to helping those living with diabetes discover the best devices to live their desired lifestyle.
New Senate Bill Would Speed up Availability of Generic Insulin in the U.S.
The Affordable Insulin Approvals Now Act is a bipartisan bill intended to speed up the approval process of generic insulins in order to help lower costs.
JDRF Advocates Urge Congress to Renew Funding for T1D Research
On the final day of the 2019 JDRF Children's Congress, advocates implored the U.S. Special Committee on Aging to renew the Special Diabetes Program.
One on One With Insulet CEO Shacey Petrovic
Insulet CEO Shacey Petrovic spoke with Beyond Type 1 about her personal connection to T1D, the importance of access, the future of Omnipod and more.
Help Emilia: A T1D Cause
Neil Greathouse asks other willing and able T1Ds to send extra supplies so that he might bring them down to Peru to help better (and possibly save) the life of a fellow T1D.
I Was Blamed for My T1D Diagnosis
Edith Mukantwari is President of the Africa Diabetes Alliance, an organization in Uganda that seeks to encourage diabetes education and bridge the information gap.
Colorado Becomes First State to Pass Bill Capping Insulin Costs
On Wednesday, May 22, Colorado became the first state in the U.S. to put a price cap on insulin.
Express Scripts Won’t Cover Lilly’s Generic Insulin
The largest PBM in the U.S. recently released a list of formulary exclusions that included 'Insulin Lispro' as an excluded medication.
Insulin Manufacturers and PBMs Testify Before Congress
The hearing was contentious throughout, with House members grilling both the manufacturers and the PBM representatives about the reasons for high costs.
Posts navigation
←
Newer
Posts
1
…
3
4
5
6
Older
Posts
→